Troyer DA - Search Results

1

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.

Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK. Brooks JD, et al. Among authors: troyer da. PLoS One. 2015 Jul 14;10(7):e0132343. doi: 10.1371/journal.pone.0132343. eCollection 2015. PLoS One. 2015. PMID: 26172920 Free PMC article.

2

Epididymal rhabdomyoma.

Matsunaga GS, Shepherd DL, Troyer DA, Thompson IM. Matsunaga GS, et al. Among authors: troyer da. J Urol. 2000 Jun;163(6):1876. J Urol. 2000. PMID: 10799212 No abstract available.

3

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. Among authors: troyer da. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

4

Risk perceptions among patients and their relatives regarding prostate cancer and its heredity.

Arar N, Thompson I, Sarosdy M, Harris M, Shepherd D, Troyer D, Plaetke R. Arar N, et al. Prostate Cancer Prostatic Dis. 2000 Nov;3(3):176-185. doi: 10.1038/sj.pcan.4500416. Prostate Cancer Prostatic Dis. 2000. PMID: 12497094

5

Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.

Thompson IM, Basler JA, Leach R, Troyer D, Klein E, Brawley O. Thompson IM, et al. Urol Oncol. 2003 Jan-Feb;21(1):73-8. doi: 10.1016/s1078-1439(02)00302-2. Urol Oncol. 2003. PMID: 12684131 Review.

6

Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.

Leach R, Pollock B, Basler J, Troyer D, Naylor S, Thompson IM. Leach R, et al. Urol Clin North Am. 2003 May;30(2):227-37. doi: 10.1016/s0094-0143(02)00178-7. Urol Clin North Am. 2003. PMID: 12735500 Review.

7

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Thompson IM, et al. Clin Prostate Cancer. 2003 Mar;1(4):215-20. doi: 10.3816/cgc.2003.n.002. Clin Prostate Cancer. 2003. PMID: 15040879 Review.

8

Relationship of body mass index and prostate specific antigen in a population-based study.

Thompson IM, Leach R, Troyer D, Pollock B, Naylor S, Higgins B. Thompson IM, et al. Urol Oncol. 2004 Mar-Apr;22(2):127-31. doi: 10.1016/S1078-1439(03)00171-6. Urol Oncol. 2004. PMID: 15082010

9

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.

Grizzle WE, Semmes OJ, Basler J, Izbicka E, Feng Z, Kagan J, Adam BL, Troyer D, Srivastava S, Thornquist M, Zhang Z, Thompson IM. Grizzle WE, et al. Urol Oncol. 2004 Jul-Aug;22(4):337-43. doi: 10.1016/j.urolonc.2004.04.008. Urol Oncol. 2004. PMID: 15283893 Review.

10

The association of body mass index and prostate-specific antigen in a population-based study.

Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozanski T, Troyer D, Thompson I. Baillargeon J, et al. Cancer. 2005 Mar 1;103(5):1092-5. doi: 10.1002/cncr.20856. Cancer. 2005. PMID: 15668913 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters